Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)
Authors:
- Peter J. SelbyPSPeter J. Selby
- Gordon CookGCGordon Cook
- 1 May 2013
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 27 (3) , 155-164
Abstract
No abstract availableKeywords
This publication has 177 references indexed in Scilit:
- Tumor Microenvironment and Myeloid-Derived Suppressor CellsCancer Microenvironment, 2012
- A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic CellsJournal of Biological Chemistry, 2011
- Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndromeEuropean Journal of Immunology, 2011
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccinationCancer Immunology, Immunotherapy, 2010
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- Decision checkpoints in the thymusNature Immunology, 2010
- Melanoma Induces Immunosuppression by Up-Regulating FOXP3+ Regulatory T CellsJournal of Surgical Research, 2007
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006
- Oral Tolerance: Therapeutic Implications for Autoimmune DiseasesJournal of Immunology Research, 2006